Approval No.: H20058980
Specifications: 0.5 ml: 3.75 mg (150,000 units)
Scope of Application: Gastrointestinal and Metabolic Drugs (see package insert for details)
Approval No.: H20249511
Specifications: 80 mg (calculated as C₆H₆O₃·2H₂O)
Scope of Application: Gastrointestinal and Metabolic Drugs (see package insert for details)
Approval No.: H20253713
Specifications: 0.2g
Scope of Application: Gastrointestinal and Metabolic Drugs (see package insert for details)
Approval No.: H20233979
Specifications: 0.9 g (calculated as C₁₆H₂₈N₂O₄)
Scope of Application: Anti-infective agents (see the package insert for details).
Approval No.: H20243442
Specifications: 0.1% (0.4 ml: 0.4 mg)
Scope of Application: Ophthalmic medication (see package insert for details)
Approval No.: H20249844
Specifications: 2 ml: 20 mg
Scope of Application: Gastrointestinal and Metabolic Drugs (see package insert for details)
Approval No.: H20054662
Specifications: 1 mL: 0.15 g (calculated as C₁₈H₃₃ClN₂O₅S)
Scope of Application: The system uses anti-infective agents (see the package insert for details).
Approval No.: H20243981
Specifications: 10 mg
Scope of Application: Drugs for the blood and hematopoietic system (see package insert for details)
Approval No.: H20234227
Specifications: 0.25 g (calculated as glucosamine sulfate) or 0.314 g (calculated as glucosamine sulfate sodium chloride)
Scope of Application: Musculoskeletal system drugs (see package insert for details)
Approval No.: H20253333
Specifications: 20mg
Scope of Application: Drugs for the blood and hematopoietic system (see package insert for details)
Star product
More products
Approval No.: H20058980
Specifications: 0.5 ml: 3.75 mg (150,000 units)
Scope of Application: Gastrointestinal and Metabolic Drugs (see package insert for details)
Approval No.: H20249511
Specifications: 80 mg (calculated as C₆H₆O₃·2H₂O)
Scope of Application: Gastrointestinal and Metabolic Drugs (see package insert for details)
Approval No.: H20253713
Specifications: 0.2g
Scope of Application: Gastrointestinal and Metabolic Drugs (see package insert for details)
Approval No.: H20233979
Specifications: 0.9 g (calculated as C₁₆H₂₈N₂O₄)
Scope of Application: Anti-infective agents (see the package insert for details).
Approval No.: H20243442
Specifications: 0.1% (0.4 ml: 0.4 mg)
Scope of Application: Ophthalmic medication (see package insert for details)
Approval No.: H20249844
Specifications: 2 ml: 20 mg
Scope of Application: Gastrointestinal and Metabolic Drugs (see package insert for details)
Approval No.: H20054662
Specifications: 1 mL: 0.15 g (calculated as C₁₈H₃₃ClN₂O₅S)
Scope of Application: The system uses anti-infective agents (see the package insert for details).
Approval No.: H20243981
Specifications: 10 mg
Scope of Application: Drugs for the blood and hematopoietic system (see package insert for details)
Approval No.: H20234227
Specifications: 0.25 g (calculated as glucosamine sulfate) or 0.314 g (calculated as glucosamine sulfate sodium chloride)
Scope of Application: Musculoskeletal system drugs (see package insert for details)
Approval No.: H20253333
Specifications: 20mg
Scope of Application: Drugs for the blood and hematopoietic system (see package insert for details)
Approval No.: H20253798
Specifications: 10 ml: 60 mg (calculated as C₁₅H₁₇NaO₃)
Scope of Application: Musculoskeletal system drugs (see package insert for details)
Approval No.: H20253548
Specifications: 20 mg (calculated as C₂₉H₃₄Cl₂N₆O₃S₂)
Scope of Application: Drugs for the blood and hematopoietic system (see package insert for details)
Approval No.: H20244150
Specifications: 60 mL: 0.3 g (calculated on the basis of C₁₅H₂₈N₄O₄)
Scope of Application: The system uses anti-infective agents (see the package insert for details).
Approval No.: H20249042
Specifications: Calculated on the basis of C₁₆H₂₂N₂O₃·HCl·1/2H₂O: 0.3 mL contains 30 μg.
Scope of Application: Respiratory system medications (see package insert for details)
Approval No.: H20256454
Specifications: 30 mg (calculated as C₂₁H₂₃NO)
Scope of Application: Reproductive and urinary system and sex hormone drugs (see package insert for details)
Approval No.: H20249336
Specifications: 5ml:100mg
Scope of Application: Cardiovascular system drugs (see package insert for details)
Approval No.: H20244901
Specifications: 5 mL: 100 mg (calculated as C₁₈H₂₃NO₃)
Scope of Application: Cardiovascular system drugs (see package insert for details)
Approval No.: H20244125
Specifications: 12mg
Scope of Application: Cardiovascular system drugs (see package insert for details)
Approval No.: H20233198
Specifications: 20 mg (calculated as C₂₂H₁₉N₃O₄)
Scope of Application: Reproductive and urinary system and sex hormone drugs (see package insert for details)
Approval No.: H37023608
Scope of Application: Gastrointestinal and Metabolic Drugs (see package insert for details)
Approval No.: H20254009
Specifications: 10 ml: 60 mg
Scope of Application: Cardiovascular system drugs (see package insert for details)
Specifications: 1 ml: 100 mg
Scope of Application: Gastrointestinal and metabolic drugs. (See the package insert for details.)
Specifications: Bottle 1: 5 ml/bottle; Bottle 2: 5 ml/bottle
Scope of Application: Gastrointestinal and metabolic drugs. (See the package insert for details.)
Specifications: 25 ml/bag
Scope of Application: Gastrointestinal and metabolic drugs. (See the package insert for details.)
Coming soon
More products
Specifications: 1 ml: 100 mg
Scope of Application: Gastrointestinal and metabolic drugs. (See the package insert for details.)
Specifications: Bottle 1: 5 ml/bottle; Bottle 2: 5 ml/bottle
Scope of Application: Gastrointestinal and metabolic drugs. (See the package insert for details.)
Specifications: 25 ml/bag
Scope of Application: Gastrointestinal and metabolic drugs. (See the package insert for details.)
Hotline
Address
No. 19, Baizhu Road, Economic and Technological Development Zone, Liuyang City, Changsha, Hunan, China
Copyright © HUNAN XIANSHI PHARMACEUTICAL CO., LTD.
This site supports IPv4 IPv6 .